Atromentin-induced apoptosis in human leukemia U937 cells

Journal of Microbiology and Biotechnology

Volumn 19, Issue 9, 2009, Pages 946-950

  Kim, Jin Hee ^a   Choong, Hwan Lee ^a  

^a Konkuk University   (South Korea)

Author keywords

Apoptosis; Atromentin; U937 cells

Indexed keywords

ANTILEUKEMIC AGENT; ATROMENTIN; CASPASE 3; CASPASE 9; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STRAIN U937; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG IDENTIFICATION; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVATION; FUNGAL STRAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKEMIA CELL; NONHUMAN;

APOPTOSIS; BENZOQUINONES; CASPASE 3; CASPASE 9; CELL DIVISION; CELL SURVIVAL; DNA FRAGMENTATION; DNA, NEOPLASM; HUMANS; PHENOLS; SOIL; U937 CELLS;

EID: 70849094103     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.0811.617     Document Type: Article

References (28)

1. Bhalla, K., A. M. Ibrado, E. Tourkina, C. Tang, S. Grant, G. Bullock, Y. Huang, V. Ponnathpur, and M. E. Mahoney. 1993. High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood 82: 3133-3140. (Pubitemid 23334941)
2. Bradham, C. A., T. Qian, K. Streetz, C. Trautwein, D. A. Brenner, and J. J. Lemasters. 1998. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol. Cell. Biol. 18: 6353-6364.
3. Choi, S. K., B. R. Seo, K. W. Lee, W. Cho, S. H. Jeong, and K. T. Lee. 2007. Saucernetin-7 isolated from Saururus chinensis induces caspase-dependent apoptosis in human promyelocytic leukemia HL-60 cells. Biol. Pharm. Bull. 30: 1516-1522.
4. Dantzer, F., V. Schreiber, C. Niedergang, C. Trucco, E. Flatter, G. De La Rubia, et al. 1999. Involvement of poly(ADP ribose) polymerase in base excission repair. Biochimie 81: 69-75.
5. De Almeida, C. J. and R. Linden. 2005. Phagocytosis of apoptotic cells: A matter of balance. Cell Mol. Life Sci. 62: 1532-1546.
6. Deveraux, Q. L. and J. C. Reed. 1999. IAP family proteins - suppressors of apoptosis. Genes Dev. 13: 239-252.
7. Evans, V. G. 1993. Multiple pathways to apoptosis. Cell Biol. Int. 17: 461-476.
8. Friesen, C., I. Herr, P. H. Krammer, and K. M. Debatin. 1996. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 2: 574-577.
9. Gaylord, M. C. and L. R. Brady. 1971. Comparison of pigments in carpophores and saprophytic cultures of Paxillus panuoides and Paxillus atrotomentosus. J. Pharm. Sci. 60: 1503-1508.
10. Goodwin, C. J., S. J. Holt, S. Downes, and N. J. Marshall. 1995. Microculture tetrazolium assays: A comparison between two new tetrazolium salts, XTT and MTS. J. Immunol. Methods 179: 95-103.
11. Guo, Y. and N. Kyprianou. 1999. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Cancer Res. 59: 1366-1371. (Pubitemid 29136271)
12. Hanahan, D. and J. Folkman. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364. (Pubitemid 26272076)
13. Hong, W. K. and M. B. Sporn. 1997. Recent advances in chemoprevention of cancer. Science 278: 1073-1077.
14. Hu, L., J. M. Gao, and J. K. Liu. 2001. Unusual poly (phenylacetyloxy)- substituted 1,1':4',1"-terphenyl derivatives from fruiting bodies of the basidiomycete Thelephora ganbajum. Helv. Chem. Acta 84: 3342-3349.
15. Huang, P. and A. Oliff. 2001. Signaling pathways in apoptosis as potential targets for cancer therapy. Trends Cell Biol. 11: 343-348. (Pubitemid 32728175)
16. Janicke, R. U., M. L. Sprengart, M. R. Wati, and A. G. Porter. 1998. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273: 9357-9360.
17. Kaufmann, S. H. 1980. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note. Cancer Res. 49: 5870-5878.
18. Lakka, S. S., C. S. Gondi, N. Yanamandra, W. C. Olivero, D. H. Dinh, M. Gujrati, and J. S. Rao. 2004. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23: 4681-4689.
19. Liu, J. K. 2006. Natural terphenyls: Developments in vascular angiogenesis. Free Radic. Biol. Med. 33: 1047-1060.
20. Maulik, N. and D. K. Das. 2002. Redox signaling in vascular angiogenesis. Free Radic. Biol. Med. 33: 1047-1060.
21. Nicholson, D. W., A. Ali, N. A. Thornberry, J. P. Vaillancourt, C. K. Gallant, Y. Gareau, P. R. Griffin, M. Labelle, and Y. A. Lazebnik. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43.
22. Pipper, A. A., A. Verma, J. Zhang, and S. H. Snyder. 1999. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol. Sci. 20: 171-181.
23. Rosse, T., R. Olivier, L. Monney, M. Rager, S. Conus, I. Fellay, B. Jansen, and C. Borner. 1998. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391: 496-499. (Pubitemid 28086551)
24. Thörner, W. 1878. Ueber eigen in einer Agaricus-art vorkommenden chinonartigen Körper. Chem. Ber. 11: 533-535.
25. Ujibe, M., S. Kanno, Y. Osanai, K. Koiwai, T. Ohtake, K. Kimura, K. Uwai, M. Takeshita, and M. Ishikawa. 2005. Octylcaggeate induced apoptosis in human leukemia U937 cells. Biol. Pharm. Bull. 28: 2338-2341.
26. Webster, K. A. 2003. Therapeutic angiogenesis: A complex problem requiring a sophisticated approach. Cardiovasc. Toxicol. 3: 283-298.
27. Woo, M., R. Hakem, M. S. Soengas, G. S. Duncan, A. Shahinian, D. Kagi, et al. 1998. Essential contribution of caspase-3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12: 806-819. (Pubitemid 28150882)
28. Zheng, C. J., M. J. Sohn, and W. G. Kim. 2006. Atromentin and leucomelone, the first inhibitors specific to enoyl-ACP reductase (FabK) of Streptococcus pneumoniae. J. Antibiot. 59: 808-812.